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Exposure to chemicals during fetal develop-
ment can increase the risk of adverse health 
consequences, including adverse birth out-
comes (e.g., preterm birth and birth defects), 
childhood morbidity (e.g., neurodevelopmental 
effects and childhood cancer), and adult dis-
ease and mortality (e.g., cancer and cardiovas-
cular effects) (Gluckman and Hanson 2004; 
Stillerman et al. 2008). Biomonitoring stud-
ies report nearly ubiquitous exposure to many 
chemicals in the U.S. population—for exam-
ple, bisphenol A (BPA), perchlorate, and cer-
tain phthalates and polybrominated diphenyl 
ethers (PBDEs) [Centers for Disease Control 
and Prevention (CDC) 2009a]. These stud-
ies, along with more geographically targeted 
studies of pregnant women, show that preg-
nant women are also exposed to many chemi-
cals (Bradman et al. 2003; Swan et al. 2005). 
Chemicals can cross the placenta and enter the 
fetus, and a number of chemicals measured in 
maternal urine and serum have also been found 
in amniotic fluid, cord blood, and meconium 
(Barr et al. 2007). In some cases, such as for 
mercury, fetal exposures may be higher than 
maternal exposure (Barr et al. 2007).
Multiple chemical exposures are of increas-
ing concern. Studies show that exposure 
to multiple chemicals that act on the same 
adverse outcome can have a greater effect than 
exposure to an individual chemical. This has 
been recognized by the National Academy 
of Sciences (NAS), which recommends that 
future efforts accounting for risks from mul-
tiple chemical exposures combine effects from 
chemicals acting on the same adverse health 
outcome (National Research Council 2008a). 
Subsequently, assessment of exposure to multi-
ple chemicals has been identified as an impor-
tant future research area (Kortenkamp 2007).
Because few data are available on levels of 
individual or multiple chemicals in pregnant 
women, levels in reproductive-age women 
have often been used as an indicator of chemi-
cal levels in pregnant women (Blount et al. 
2000). Some studies have directly compared 
pregnant women in their cohort and reproduc-
tive-age women from the National Health and 
Nutritional Examination Survey (NHANES), 
a nationally representative sample of the U.S. 
population. For example, phthalates measured 
in pregnant women from three U.S. locations 
were lower than those measured in reproduc-
tive-age women from NHANES (Swan et al. 
2005). Numerous physiological changes occur 
during pregnancy, including weight gain 
and increases in blood and plasma volume, 
which can affect concentrations of chemicals 
(Chesley 1972; Pirani and Campbell 1973). 
Chemicals may also concentrate in the fetus, 
which could influence maternal concentra-
tions (Takahashi and Oishi 2000). Further, 
behavioral changes occurring during preg-
nancy, such as diet modification (e.g., quantity 
and food type), may also influence chemical 
body burdens in pregnant women (Mirel et al. 
2009). Understanding whether some of these 
factors can influence maternal concentrations 
of chemicals helps inform our ability to use 
measurements of chemicals in nonpregnant 
women as a surrogate for pregnant women.
We analyzed biomonitoring data for preg-
nant women from NHANES to characterize 
exposure to individual and multiple chemi-
cals and their metabolites in pregnant women. 
Additionally, we evaluated the extent to which 
levels measured in nonpregnant women are 
representative of levels in pregnant women, and 
what factors may explain observed differences.
Methods
Study population. NHANES, conducted by 
the CDC, is a nationally representative survey 
and physical examination assessing the health 
and nutritional status of the civilian, nonin-
stitutionalized U.S. population. The survey 
also includes measurement of chemicals and 
their metabolites in blood and urine (for more 
information, see CDC 2010). We use the 
term “chemical analyte” here to describe both 
chemicals and their metabolites. Because of the 
complex stratified survey design in NHANES, 
separate sample weights are assigned to each 
survey respondent; each participant represents 
approximately 50,000 other U.S. residents. 
Pregnant women were oversampled in the 
NHANES survey from 2001 to 2006 (CDC 
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2009b). [Protocols for oversampling preg-
nant women are described in Supplemental 
Material (doi:10.1289/ehp.1002727) and in 
detail elsewhere (Mirel et al. 2009).] We clas-
sified pregnancy status according to the results 
of the urine pregnancy test administered as 
part of NHANES protocols.
Most chemical analytes were measured in 
subsets of the total NHANES sample. Each 
subset included about one-third the total num-
ber of participants, so not all chemical analytes 
were measured in each participant. Further, not 
every group of chemical analytes was measured 
in each cycle. Therefore, we analyzed the 2003–
2004 cycle, because it represents the cycle with 
the highest number of chemical analytes meas-
ured across the sample of pregnant women. We 
limited our study population to those 15–44 
years of age to be consistent with the definition 
used by the National Center for Health Statistics 
for women of childbearing age (Chandra et al. 
2005). Therefore, our study population includes 
268 pregnant women and 1,489 nonpregnant 
women 15–44 years of age included in at least 
one subsample for chemical analyte analysis.
Environmental chemical analyte analy-
ses. Chemical analyte analyses were conducted 
at the National Center for Environmental 
Health laboratories (CDC, Atlanta, GA). 
Analytical procedures and summary statistics 
for the general population have been described 
in the Fourth National Report on Human 
Exposure to Environmental Chemicals and 
in the peer-reviewed literature (Calafat et al. 
2008; Caldwell et al. 2009; CDC 2009a; 
Sjodin et al. 2008). We assessed 163 chemical 
analytes across 12 chemical classes (Table 1), 
measured in blood, urine, and serum.
Data analysis. We conducted analyses in 
SUDAAN (version 10.0; Research Triangle 
Institute, Research Triangle Park, NC) and 
SAS (version 9.2; SAS Institute Inc., Cary, 
NC). SUDAAN calculates variance estimates 
after incorporating the nonrandom sampling 
design and the sample population weights, 
which account for oversampling of certain 
subgroups.
We examined summary statistics and dis-
tributional plots for each chemical analyte. We 
calculated the following descriptive statistics [for 
further details on analysis, see Supplemental 
Material (doi:10.1289/ehp.1002727)]: percent-
age of women with levels greater than the limit 
of detection (LOD), geometric mean (GM), 
geometric standard error (GSE), median and 
95th percentile estimates, and the coefficient 
of variation (CV; defined as the GSE divided 
by the GM). The GM, GSE, and CV were 
calculated only for chemical analytes with 
> 60% detection frequency. The median and 
95th percentile were calculated for all chemi-
cal analytes. Concentrations below the LOD 
were substituted by the CDC with LOD/√
– 2. 
We present statistical results for individual 
chemical analytes in the main text that are rep-
resentative of each chemical class [for descrip-
tive statistics and LODs for all 163 chemical 
analytes, see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002727)]. Representative 
chemical analytes were chosen based on public 
health relevance and expectation of relatively 
widespread exposure.
To assess extent of multiple exposures 
within a chemical class, we evaluated the 
Table 1. Chemical classes measured in biological tissue of pregnant women, NHANES 2003–2004.
No. of chemical analytes measured
Chemical class Blood Serum Urine Total
Cotinine 1 1
Environmental phenols 4 4
Metals 4 4
Organochlorine pesticides 13 13
Organophosphate insecticides 6 6
Perchlorate 1 1
Phthalates 13 13
PBDEs and other brominated flame retardants 11 11
PCBs and dioxin-like chemicals 55 55
PAHs 10 10
PFCs 12 12
VOCs 33 33
See Supplemental Material, Table 1 (doi:10.1289/ehp.1002727), for individual chemical analytes included in each 
  chemical class.
Table 2. Characteristics of reproductive-age women by pregnancy status, NHANES 2003–2004.
Demographic characteristic
Pregnant women 
(n = 268)
Nonpregnant women 
(n = 1,489)
Age [years (mean ± SE)]** 27 ± 0.8 30 ± 0.37
Age [years (%)]**
15–17 4 10
18–24 30 23
25–29 31 13
30–34 25 17
35–44 11 37
Race/ethnicity (%)**
Non-Hispanic white 56 67
Non-Hispanic black 18 14
Mexican American 17 10
Other Hispanic 2 5
Other 6 5
Education (%)
< High school diploma 26 24
High school diploma 15 22
> High school diploma 59 54
Marital status (%)**
Married or living with partner 79 50
Divorced, separated, or widowed 2 12
Never married 19 38
Parity (%)**
0 45 44
1 34 14
≥ 2 21 42
Smoking status (%)**
Never 59 60
Former 31 11
Current 9 30
Trimester
First 31
Second 32
Third 37
Biochemical measurements
Serum albumin [g/dL (mean ± SE)]** 3.46 ± 0.04 4.23 ± 0.01
Urinary creatinine [mg/dL (mean ± SE)] 127.81 ± 6.00 130.86 ± 3.27
Sampling characteristics
Duration of food and drink fasting before 
blood collection [hr (mean ± SE)]**
8.40 ± 0.73 10.67 ± 0.10
Data were missing in pregnant women for parity (n = 18), education (n = 3), smoking (n = 6), trimester (n = 41), and length 
of fasting (n = 2) and in nonpregnant women for parity (n = 160), education (n = 46), smoking (n = 151), and length of fasting 
(n = 25). 
**p < 0.01. Woodruff et al.
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number of individual PBDEs, perfluorinated 
compounds (PFCs), organochlorine pesti-
cides, and phthalates detected in each preg-
nant woman. We chose these chemical classes 
to represent banned persistent chemicals 
(organochlorine pesticides), persistent chemi-
cals (PBDEs and PFCs), and currently used 
nonpersistent chemicals (phthalates).
We then evaluated the extent of multiple 
chemical exposures across chemical classes in 
three different subsamples. These three sub-
samples were the primary subsamples of the 
pregnant women. Pregnant women in sub-
sample A were assessed for metals, cotinine, 
and PFCs (17 chemical analytes in 76 women); 
in subsample B, for metals, cotinine, organo-
chlorine pesticides, phthalates, PBDEs, and 
polycyclic aromatic hydrocarbons (PAHs) (52 
chemical analytes in 54 women); and in sub-
sample C, for metals, phenols, polychlorinated 
biphenyls (PCBs), organophosphate insecti-
cide metabolites, perchlorate, and cotinine (71 
chemical analytes in 59 women) [for subsam-
ple composition, see Supplemental Material, 
Table 2 (doi:10.1289/ehp.1002727)]. Volatile 
organic compounds (VOCs) were measured 
only in a subsample of pregnant women that 
partially overlapped with subsamples A, B, and 
C. Consequently, we did not include VOCs in 
analyses of multiple chemical exposures.
To compare chemical analyte concentra-
tions between pregnant and nonpregnant 
women, we constructed multivariate regres-
sion models, which included our main effect 
(binary pregnancy status variable) along with 
covariates. We log-transformed chemical 
analytes before regression analysis to account 
for the nonnormal distributions. From these 
models, we calculated the least-squares geo-
metric means (LSGMs), which provide GM 
estimates after adjustment for other covari-
ates. For every chemical analyte in the main 
analysis, we used the same set of covariates. 
Covariates were included if they were signifi-
cant predictors of more than one chemical 
Table 3. Descriptive statistics for chemical analytes in pregnant and nonpregnant women, NHANES 2003–2004.a
Chemical analyte n
Reproductive 
status LODa
Percent 
> LOD GM (GSE)
50th 
percentile
95th 
percentile CV
Metals [blood (μg/L)]
Cadmium** 253 Pregnant 0.14 66 0.22 (0.01) 0.2 0.8 0.07
1,396 Nonpregnant 79 0.33 (0.01) 0.3 1.6 0.03
Lead (μg/dL)** 253 Pregnant 0.28 94 0.68 (0.04) 0.6 1.8 0.06
1,396 Nonpregnant 99 0.96 (0.04) 0.9 2.4 0.04
Mercury (total)* 253 Pregnant 0.20 89 0.67 (0.07) 0.7 3.4 0.10
1,396 Nonpregnant 92 0.80 (0.05) 0.8 4.4 0.06
VOCs [blood (μg/L)]
Benzene 89 Pregnant 0.024 38 —b < LOD 0.2 —b
389 Nonpregnant 53 —b < LOD 0.3 —b
1,4-Dichlorobenzene 89 Pregnant 0.12 40 —b < LOD 20.0 —b
373 Nonpregnant 47 —b < LOD 4.1 —b
MTBE (methyl tert-butyl ether) 85 Pregnant 0.002 86 0.01 (0.01) 0.02 0.1 0.40
373 Nonpregnant 78 0.01 (0.002) 0.01 0.1 0.20
Toluene** 90 Pregnant 0.025 94 0.07 (0.01) 0.1 0.2 0.07
387 Nonpregnant 95 0.10 (0.01) 0.1 0.5 0.10
Cotinine [serum (μg/L)]** 249 Pregnant 0.015 66 0.07 (0.02) 0.03 68.8 0.31
1,369 Nonpregnant 83 0.54 (0.13) 0.1 318.0 0.24
PFCs [serum (μg/L)]
Perfluorooctanoic acid* 76 Pregnant 0.1 99 2.39 (0.24) 2.6 5.6 0.10
400 Nonpregnant 99 3.19 (0.16) 3.2 8.4 0.05
PFOS (perfluorooctanyl sulfonate)** 76 Pregnant 0.4 99 12.29 (1.02) 12.0 21.8 0.08
400 Nonpregnant 100 16.26 (0.84) 15.5 44.0 0.05
PBDEs [serum (ng/g lipid)]
PBDE-47 75 Pregnant 4.2 99 23.90 (2.21) 23.7 100.0 0.09
441 Nonpregnant 98 21.15 (2.03) 21.2 114.0 0.10
PBDE-99 75 Pregnant 5.0 87 5.51 (0.81) 5.1 21.8 0.15
434 Nonpregnant 68 5.04 (0.42) 4.4 31.5 0.08
PBDE-100* 75 Pregnant 1.4 99 6.06 (0.91) 6.6 23.2 0.15
443 Nonpregnant 96 4.00 (0.43) 3.8 25.2 0.11
PBDE-153 75 Pregnant 2.2 100 9.90 (3.04) 7.8 127.0 0.31
442 Nonpregnant 93 5.18 (0.53) 4.5 43.9 0.10
PCBs [serum (ng/g lipid)]
PCB-118 75 Pregnant 0.6 100 4.31 (0.95) 3.6 14.3 0.22
415 Nonpregnant 100 4.46 (0.28) 4.3 16.9 0.06
PCB-138 and -158 75 Pregnant 0.4 100 7.70 (1.24) 7.3 20.2 0.16
416 Nonpregnant 100 8.95 (0.55) 8.3 37.0 0.06
PCB-153 75 Pregnant 1.1 100 8.74 (1.29) 8.8 22.5 0.15
415 Nonpregnant 100 11.07 (0.64) 10.2 44.0 0.06
PCB-180* 75 Pregnant 0.4 96 4.61 (0.99) 6.8 13.2 0.21
416 Nonpregnant 99 7.42 (0.44) 7.5 33.3 0.06
Organochlorine pesticides [serum (ng/g lipid)]
DDT (dichlorodiphenyltrichloroethane)  71 Pregnant 7.8 62 —c —c 37.4 0.16
426 Nonpregnant 63 —c —c 13.3 0.06
DDE 
(dichlorodiphenyldichloroethylene)
71 Pregnant 7.8 100 140.39 (29.72) 99.9 850.0 0.21
424 Nonpregnant 99 151.04 (16.03) 141.0 815.0 0.11
Hexachlorobenzene* 70 Pregnant 7.8 100 11.27 (1.08) 10.4 25.7 0.10
428 Nonpregnant 99 14.34 (0.39) 14.3 25.7 0.03
continued next pageNHANES and chemicals in pregnant women
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analyte or if their inclusion in the model 
changed the β-coefficient for the main effect 
by > 20%. The following covariates were 
evaluated: age (continuous), race/ethnicity 
(Mexican American, non-Hispanic white, 
non-Hispanic black, or other), education 
(high school diploma or less vs. more than 
high school diploma), marital status (married/
living with a partner, divorced/separated, or 
never married), parity (number of pregnancies 
resulting in live births, nulliparous vs. one or 
more child), current body mass index (BMI; 
continuous), smoking status (never, former, or 
current), serum albumin (continuous), length 
of food and drink fasting before blood collec-
tion (0–4.5 hr, 4.5–8.5 hr, or 8.5–24 hr), and 
urinary creatinine (continuous). All regression 
models were adjusted for the same covariates 
except for creatinine (included in models for 
urinary chemicals only). We excluded 12 non-
pregnant women who reported fasting times 
> 24 hr. We defined statistical significance as 
p < 0.10 for all analyses because of relatively 
small number of pregnant women sampled for 
each chemical analyte and, consequently, small 
degrees of freedom.
As a sensitivity analysis, we performed 
multivariate regression in women < 35 years 
of age, because the age distribution differed 
between the two groups. For this analysis, we 
selected model covariates separately for each 
individual chemical analyte using the covari-
ate selection method described above. Thus, 
the covariates in the sensitivity analysis may 
differ from that used in the main analysis. 
We conducted sensitivity analyses for lead (n 
= 215 pregnant; n = 885 nonpregnant), BPA 
(n = 63 pregnant; n = 275 nonpregnant), and 
p,p´-dichlorodiphenyldichloroethene (DDE) 
(n = 65 pregnant; n = 380 nonpregnant).
Results
Although most pregnant and nonpregnant 
women were white, there was a higher per-
centage of Mexican-American pregnant 
women compared with nonpregnant women, 
reflecting higher birth rates among Hispanic 
women in the United States (Table 2) 
(Martin et al. 2007). Nonpregnant women 
were older, less likely to be married or with a 
partner, and more likely to smoke than were 
pregnant women (Table 2). In addition, preg-
nant women had lower levels of albumin and 
shorter fasting times before blood collection 
than did nonpregnant women.
Table 3 summarizes statistics for pregnant 
and nonpregnant women for select chemi-
cal analytes [for all 163 chemical analytes in 
pregnant women, see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002727)]. We 
found that 0–100% of pregnant women had 
a detectable level across the individual chem-
ical analytes. Eight of 12 classes of chemi-
cals included individual chemical analytes 
detected in 99–100% of pregnant women 
(PFCs, PBDEs, PCBs, organochlorine pes-
ticides, phenols, phthalates, PAHs, and per-
chlorate). Four classes (VOCs, PFCs, PCBs, 
and organochlorine pesticides) included 
Table 3. continued.
Chemical analyte n
Reproductive 
status LODa
Percent 
> LOD GM (GSE)
50th 
percentile
95th 
percentile CV
Organophosphate insecticide metabolites [urine (μg/L)]
Dimethylphosphate 89 Pregnant 0.5 44 —b < LOD 13.7 —b
483 Nonpregnant 48 —b < LOD 14.3 —b
Diethylphosphate 89 Pregnant 0.1 33 —b < LOD 10.8 —b
474 Nonpregnant 49 —b < LOD 14.8 —b
DMTP* 89 Pregnant 0.5 83 2.43 (0.43) 2.7 16.0 0.18
483 Nonpregnant 73 1.81 (0.17) 1.7 28.3 0.09
Diethylthiophosphate 87 Pregnant 0.2 57 —b 0.2 2.2 —b
478 Nonpregnant 46 —b < LOD 2.6 —b
Dimethyldithiophosphate 86 Pregnant 0.1 56 —b 0.2 3.2 —b
475 Nonpregnant 34 —b < LOD 4.0 —b
Environmental phenols [urine (μg/L)]
BPA 86 Pregnant 0.4 96 2.53 (0.63) 2.7 15.0 0.25
489 Nonpregnant 96 2.89 (0.29) 3.0 17.6 0.10
Triclosan 86 Pregnant 2.3 87 17.00 (8.74) 8.2 283.0 0.51
489 Nonpregnant 81 14.65 (0.97) 11.1 411.0 0.07
Benzophenone-3 86 Pregnant 0.3 100 25.49 (6.52) 16.9 353.0 0.26
489 Nonpregnant 98 37.14 (6.44) 31.4 1530.0 0.17
Phthalates [urine (μg/L)]
Monobenzyl phthalate 91 Pregnant 0.1 100 15.12 (3.79) 17.8 86.8 0.25
497 Nonpregnant 100 14.77 (0.79) 15.5 99.9 0.05
Monoisobutyl phthalate 91 Pregnant 0.3 99 3.47 (0.84) 4.4 19.5 0.24
497 Nonpregnant 98 4.21 (0.27) 4.5 21.1 0.06
Mono-n-butyl phthalate 91 Pregnant 0.4 99 18.83 (4.11) 17.1 143.8 0.22
497 Nonpregnant 99 24.64 (1.16) 25.7 132.2 0.05
MEP 91 Pregnant 0.4 100 226.53 (79.03) 265.7 2263.0 0.35
497 Nonpregnant 100 246.06 (29.56) 234.5 2992.6 0.12
PAHs [urine (μg/L)]
9-Hydroxyfluorene 85 Pregnant 0.005 100 0.21 (0.04) 0.2 0.8 0.19
478 Nonpregnant 100 0.30 (0.03) 0.2 1.1 0.11
2-Naphthol 91 Pregnant 0.031 100 2.49 (0.59) 2.4 14.7 0.24
492 Nonpregnant 100 3.68 (0.31) 3.3 28.7 0.08
2-Hydroxyphenanthrene 87 Pregnant 0.005 100 0.06 (0.01) 0.05 0.2 0.17
479 Nonpregnant 99 0.06 (0.004) 0.06 0.3 0.07
1-Hydroxypyrene 86 Pregnant 0.005 100 0.08 (0.02) 0.08 0.5 0.25
481 Nonpregnant 99 0.09 (0.007) 0.09 0.6 0.07
Perchlorate [urine (μg/L)]* 89 Pregnant 0.05 100 4.17 (0.84) 4.3 34.0 0.07
492 Nonpregnant 100 2.68 (0.21) 2.8 11.0 0.08
aFor most chemicals, the LOD is constant across samples. However, for persistent organic pollutants (PBDEs, PCBs, and organochlorine pesticides), each individual sample has its 
own LOD because the available sample volume differed by sample, and a higher sample volume results in a lower LOD. For chemicals with sample-specific LODs, the maximum LOD is 
reported. In general, the average LOD is approximately 40–50% of the maximum LOD (CDC 2009). bGM ,GSE, or CV could not be calculated because detection frequency is< 60%. cGM or 
percentile estimate is not reported because it is less than the maximum LOD. *p < 0.10; **p < 0.01; calculated using univariate regression analysis. Woodruff et al.
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at least one individual chemical analyte 
not detected in any pregnant women [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002727)]. In general, organophosphate 
metabolites, VOCs, and dioxins and furans 
were less frequently detected in pregnant 
women than were the other chemical classes 
except for dimethylthiophosphate (DMTP), 
toluene, m- and p-xylene, and methyl tert-
butyl ether (MTBE).
Among pregnant women, DDE had the 
highest GM concentration (140.4 ng/g lipid) 
of the persistent, lipophilic compounds meas-
ured in serum (PCBs, PBDEs, and organo-
chlorine pesticides), whereas concentrations 
of most of the other measured chemical ana-
lytes in these classes were an order of magni-
tude lower (PCBs, 4–8 ng/g lipid; PBDEs, 
5–23 ng/g lipid). Perfluorooctane sulfonic acid 
(PFOS) had the highest GM among the per-
sistent chemical analytes that do not accumu-
late in lipids (e.g., lead, cadmium, and PFCs). 
Of the nonpersistent chemical analytes meas-
ured in urine (organophosphate metabolites, 
phenols, phthalates, PAHs, and perchlorate), 
triclosan, benzophenone-3, and monoethyl 
phthalate (MEP) had the highest GMs (17.00, 
25.49, and 226.53 μg/L, respectively).
Although the GM for cotinine was < 1 
μg/L, the range of concentrations spanned 
three orders of magnitude (CV = 0.31). 
Variability in other chemical analyte levels 
measured in pregnant women was generally 
low (CV < 0.25), except for some phenols (CV 
= 0.25–0.51), phthalates (CV = 0.22–0.35), 
MTBE (CV = 0.40), triclosan (CV = 0.51), 
and PBDE-153 (CV = 0.31).
Figure 1 shows the numbers of individual 
PFC, PBDE, organochlorine pesticide, and 
phthalate chemical analytes detected in indi-
vidual pregnant women. At least two organo-
chlorine pesticides, one PBDE, two PFCs, 
and four phthalates were measured in each 
pregnant woman. The median number of 
chemicals detected for organochlorine pes-
ticides, PBDEs, PFCs, and phthalates were 
6, 6, 4, and 9, respectively. For PBDEs and 
phthalates, 7% and 2%, respectively, had 
detectable levels of ≥ 90% of the chemical 
analytes in the class.
The median number of chemical analytes 
detected among women in subsamples A, 
B, and C were 8 (range, 4–12), 37 (range, 
28–45), and 50 (range, 35–60), respec-
tively (Figure 2). We found generally that 
the overall number of chemicals detected was 
not dominated by detects within a particular 
chemical class (Figure 3). For example, several 
participants in subsample B at the median 
detected level (37 chemicals) had 10 phtha-
lates, 10 PAHs, 7 PBDEs, 6 organochlorine 
pesticides, 3 metals, and cotinine detected.
GM and median levels for most chemicals 
were similar to or lower than those in preg-
nant than in nonpregnant women, except for 
PBDEs, DMTP, triclosan, and perchlorate 
(Table 3). About half the LSGM estimates 
for pregnant women (Table 4) increased after 
adjusting for covariates (Tables 3 and 4). For 
a few chemicals, the LSGM estimates for preg-
nant women decreased after adjustment, such as 
PBDEs, some phthalates, perchlorate, and BPA. 
In general, adjusted LSGMs were comparable 
between pregnant and nonpregnant women 
(Table 4). Nonpregnant women had signifi-
cantly higher levels of cadmium, lead, PFOS, 
BPA, and cotinine, but pregnant women had 
significantly higher levels of DDE, DMTP, 
MTBE, and perchlorate (Table 4). The most 
pronounced differences between pregnant and 
nonpregnant women were for MTBE and 
DMTP (levels in pregnant women were about 
two times those of nonpregnant women) and 
cotinine (levels in pregnant women were about 
half those of nonpregnant women).
Serum albumin influenced the comparison 
between pregnant and nonpregnant women 
for 28 of the 32 compounds evaluated in 
regression analyses (the β-coefficient changed 
by > 20%); however, direction of the effect 
varied by type of compound. In general, for 
chemical analytes measured in blood, effect 
estimates for albumin were positive, and their 
inclusion increased the LSGMs for pregnant 
women; in contrast, for nonpersistent urinary 
chemical analytes, the albumin effect estimates 
were more often negative, and their inclusion 
Figure 1. Distribution of the number of chemicals detected in U.S. pregnant women for four chemical 
classes: organochlorine pesticides (A; n = 71), PBDEs (B; n = 75), PFCs (C; n = 76), and phthalates (D; n = 91).
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decreased the LSGMs for pregnant women 
(data not shown). Smoking influenced com-
parison of LSGMs between pregnant and 
nonpregnant women for 75% of chemicals. 
Maternal age and BMI changed the LSGMs 
for persistent organic pollutants such as PCBs, 
and creatinine influenced LSGMs for most 
chemical analytes measured in urine. Other 
variables, such as race/ethnicity and education, 
were often significant predictors of chemical 
analyte concentrations but generally did not 
change LSGM comparisons in Table 4.
Compared with estimates based on 
women of all ages, LSGMs for lead and 
DDE for both pregnant and nonpregnant 
women were reduced when we restricted 
analyses to younger women (< 35 years of 
age). However, relative differences in adjusted 
estimates between pregnant and nonpreg-
nant women were not substantially affected. 
LSGMs for BPA increased for both groups 
in the restricted analysis, and the differences 
in LSGM estimates between pregnant and 
nonpregnant women were no longer statisti-
cally significant [LSGM = 2.16 (pregnant) vs. 
3.03 μg/L (nonpregnant), p = 0.24].
Discussion
We found widespread exposure to pregnant 
women in the United States to multiple chem-
ical analytes, including both banned and con-
temporary contaminants. Although we did 
not make any direct connection to potential 
adverse health consequences, levels of many of 
these chemical analytes were similar to those 
measured in epidemiologic studies finding an 
association between prenatal chemicals expo-
sure and adverse reproductive and develop-
mental outcomes. These include phthalates and 
increased risk of adverse male reproductive out-
comes (Swan et al. 2005), mercury and devel-
opmental neurological outcomes (Lederman 
et al. 2008), PBDEs and neurodevelopmental 
outcomes (Herbstman et al. 2010), and PCBs 
and maternal thyroid hormone disruption dur-
ing pregnancy (Chevrier et al. 2008).
Additionally, pregnant women were 
exposed to multiple chemical analytes at one 
time, many of which can affect the same 
adverse outcomes. Examples include maternal 
thyroid hormone disruption [e.g., perchlo-
rate, PCBs, PBDEs, and triclosan (Crofton 
2008)], male reproductive development (mul-
tiple phthalates), and the developing brain 
(mercury, lead, PCBs) (National Research 
Council 2008a). The NAS has recommended 
risk assessment of multiple chemicals expand 
to account for chemicals acting on a common 
adverse outcome (National Research Council 
2008a). Although the NAS focused on group-
ing chemicals contributing to disturbances 
of androgen action, they also proposed this 
approach for chemicals affecting brain devel-
opment (National Research Council 2008a).
Levels of chemicals measured during preg-
nancy can be influenced by physiological (e.g., 
changes in BMI, plasma volume expansion, 
and bone mobilization) and behavioral factors. 
For example, previous research has found an 
inverse relationship between weight gain dur-
ing pregnancy and levels of persistent organic 
pollutants in pregnant women (Bradman et al. 
2006). We found that plasma volume expan-
sion, using the level of albumin as a surrogate, 
may also influence chemical levels measured 
in pregnant women. Plasma volume begins to 
expand in pregnant women at around 8 weeks 
of gestation and increases progressively until 
30–34 weeks gestation, when it plateaus. This 
expansion may dilute environmental chemi-
cal concentrations in blood (Faupel-Badger 
et al. 2007). Accurately measuring plasma vol-
ume expansion is expensive and ideally requires 
multiple measurements throughout pregnancy 
(Faupel-Badger et al. 2007). However, albumin 
measurements may provide a reasonable surro-
gate because previous studies suggest that blood 
volume expansion dilutes circulating levels of 
albumin during pregnancy (Honger 1968). 
We found that, in general, adjusting for albu-
min increased GM estimates of persistent com-
pounds, such as DDE, in pregnant women, 
suggesting that the concentration is diluted by 
increased plasma volume. However, adjust-
ment for albumin generally decreased estimates 
for nonpersistent compounds, such as BPA, in 
pregnant women, suggesting that lower albu-
min may be associated with an increased clear-
ance of environmental contaminants. Albumin 
may affect metabolism and transport of chemi-
cals by mechanisms other than plasma volume 
expansion. For example, previous research has 
shown that PFCs actually bind to albumin 
in the blood (Jones et al. 2003). BPA also 
binds to plasma proteins, such as albumin, in 
humans (Teeguarden et al. 2005), so reduced 
albumin during pregnancy may influence the 
amount of BPA that undergoes phase II con-
jugation and subsequent elimination through 
urine. The role of albumin, and other transport 
proteins, in the transport and metabolism of 
environmental chemicals, particularly during 
pregnancy, is an important topic and requires 
further research.
We found that, generally, the levels in 
pregnant women were similar to or lower 
than levels measured in nonpregnant women. 
Adjusting for physiological factors that may 
influence levels of chemicals in pregnant 
women tended to increase the levels in preg-
nant women compared with nonpregnant 
women. This suggests that generally levels of 
chemicals in nonpregnant reproductive-age 
women are reasonably representative of lev-
els found in pregnant women. However, for 
several chemicals, levels in pregnant women 
remain lower than those in nonpregnant 
women. Behavioral factors may explain this 
difference (e.g., cotinine and smoking), or 
other physiological factors may be important 
[e.g., chemical levels concentrating in the fetus 
such as for BPA (Takahashi and Oishi 2000)].
The NHANES study design, where 
groups of chemicals were analyzed in approxi-
mate one-third–sized subsamples, meant that 
we could not evaluate more than 71 chemical 
analytes in any individual pregnant women, 
or about 44% of chemical analytes measured 
Figure 3. Number of chemicals detected by chemical class in U.S. pregnant women, NHANES subsample B 
[metals, cotinine, organochlorine (OC) pesticides, phthalates, brominated flame retardants (PBDEs), and 
PAHs], 2003–2004 (n = 54). Each vertical bar represents one study participant. Other subsamples showed 
similar results.
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during 2003–2004. This also limited our 
ability to assess exposures to multiple chemi-
cal analytes that may be acting on the same 
adverse outcome (e.g., PBDEs and PCBs, 
which can affect neurodevelopment, were 
not measured in the same women). Given 
that several chemical analytes within each of 
the classes were detected almost ubiquitously, 
pregnant women have more detectable chemi-
cal analytes than we could assess in any indi-
vidual participant in this analysis.
Other methodological changes between 
cycles make it challenging to compare data 
across NHANES cycles. For example, the num-
ber and types of chemicals sampled changes by 
cycle. Another challenge is that LODs vary 
among the cycles. Mostly they decreased, such 
as with PCBs, which can increase the number 
of chemicals detected. However, a few LODs 
increased; for example, certain urinary phtha-
late esters, such as mono-2-ethylhexyl phtha-
late (MEHP) and MEP, increased between 
2003–2004 and 2005–2006.
Chemical analyte concentrations in 
NHANES participants should be represen-
tative of typical U.S. concentrations. Thus, 
highly exposed subpopulations may be under-
represented. For example, women living in 
the agricultural Salinas Valley of California 
had higher measurable levels of several pesti-
cides than did NHANES pregnant women 
(Castorina et al. 2010). Other subpopulations 
may have nonrepresentative exposure patterns, 
such as high fish consumption or higher use of 
certain personal care products.
Our analysis indicates high variability in 
exposures for some chemical analytes, shown 
by the relatively high CV for phenols, phtha-
lates, cotinine, and MTBE. For some of these 
analytes, with almost an order of magnitude 
difference between the median and the 95th 
percentile, variation may reflect geographic 
variability in exposure sources. For example, 
MTBE was used in reformulated gasoline 
starting in 1995. Reformulated gasoline was 
required for use year-round in cities with sig-
nificant smog problems (Energy Information 
Administration 2008), so it was not used in 
Table 4. Comparison of chemical analyte concentrations between pregnant and nonpregnant women after adjustment for covariates,a calculated from multi-
variate regression models.
Pregnant women Nonpregnant women
Chemical analyte β-Coefficient (90% CI)b LSGM 90% CI LSGM 90% CI
Metals [blood (μg/L)] n = 225 n = 1,091
Cadmium –0.20 (–0.36 to –0.04)* 0.27 0.23–0.31 0.33 0.31–0.35
Lead (μg/dL) –0.16 (–0.27 to –0.06)* 0.80 0.72–0.89 0.94 0.89–0.99
Mercury (total) –0.11 (–0.33 to 0.10) 0.71 0.57–0.89 0.79 0.72–0.88
VOCs [blood (μg/L)] n = 82 n = 334
MTBE 0.97 (0.03 to 1.90)* 0.02 0.01–0.06 0.008 0.005–0.01
Toluene 0.15 (–0.14 to 0.43) 0.11 0.08–0.14 0.09 0.08–0.10
Cotinine [serum (μg/L)] n = 225 n = 1,091
–0.94 (–1.39 to –0.48)** 0.19 0.13–0.28 0.49 0.42–0.58
PFCs [serum (μg/L)] n = 70 n = 313
Perfluorooctanoic acid –0.18 (–0.37 to 0.02) 2.69 2.18–3.32 3.22 2.95–3.52
PFOS –0.23 (–0.35 to –0.12)** 12.81 11.94–13.74 16.28 15.18–17.46
PBDEs [serum (ng/g lipid)] n = 68 n = 366
PBDE-47 0.02 (–0.32 to 0.35) 21.76 16.73–28.30 21.33 18.21–24.97
PBDE-99 –0.11 (–0.47 to 0.26) 4.62c 3.37–6.33 5.10 4.44–5.87
PBDE-100 0.24 (–0.22 to 0.70) 5.21 3.60–7.52 4.10 3.38–4.97
PBDE-153 0.51 (–0.10 to 1.12) 8.85 5.05–15.50 5.31 4.46–6.33
PCBs [serum (ng/g lipid)] n = 66 n = 334
PCB-118 –0.02 (–0.31 to 0.28) 4.39 3.20–6.02 4.44 3.99–4.93
PCB-138 and -158 –0.07 (–0.33 to 0.19) 8.25 6.57–10.36 8.85 7.96–9.83
PCB-153 –0.11 (–0.39 to 0.17) 9.87 7.73–12.62 11.02 9.92–12.25
PCB-180 –0.27 (–0.65 to 0.11) 5.64 3.97–8.01 7.39 6.77–8.07
Organochlorine pesticides [serum (ng/g lipid)] n = 64 n = 354
DDT  –0.10 (–0.32 to 0.13) 3.49c 2.78–4.38 3.86c 3.60–4.14
DDE 0.33 (0.12 to 0.53)* 198.34 160.72–244.78 142.59 126.13–161.21
Hexachlorobenzene –0.02 (–0.14 to 0.10) 13.74 12.36–15.26 14.01 13.53–14.51
Organophosphate insecticide metabolites [urine (μg/L)] n = 74 n = 370
DMTP 0.85 (0.34 to 1.35)* 4.39 2.74–7.05 1.88 1.60–2.20
Environmental phenols [urine (μg/L)] n = 72 n = 371
BPA –0.55 (–0.97 to –0.13)* 1.63 1.13–2.36 2.83 2.42–3.31
Triclosan 0.47 (–0.60 to 1.54) 23.81 8.17–69.36 15.03 13.06–17.29
Benzophenone-3 –0.07 (–1.26 to 1.12) 38.09 14.02–103.46 40.85 29.28–57.00
Phthalates [urine (μg/L)] n = 75 n = 377
Monobenzyl phthalate –0.02 (–0.53 to 0.50) 14.73 8.86–24.49 15.03 13.77–16.41
Monoisobutyl phthalate –0.37 (–0.76 to 0.03) 2.83 1.89–4.23 4.06 3.65–4.50
Mono-n-butyl phthalate –0.26 (–0.62 to 0.11) 18.36 12.93–26.07 23.81 21.81–25.99
MEP –0.13 (–0.93 to 0.66) 221.41 98.85–495.90 254.68 206.36–314.30
PAHs [urine (μg/L)] n = 74 n = 372
9-Hydroxyfluorene –0.15 (–0.50 to 0.19) 0.20 0.14–0.28 0.23 0.21–0.26
2-Naphthol –0.15 (–0.57 to 0.27) 3.00 1.97–4.58 3.49 3.20–3.81
2-Hydroxyphenanthrene –0.12 (–0.27 to 0.02) 0.05 0.04–0.06 0.06 0.05–0.06
1-Hydroxypyrene –0.14 (–0.46 to 0.19) 0.08 0.06–0.10 0.09 0.08–0.09
Perchlorate [urine (μg/L)] n = 74 n = 374
0.25 (0.05 to 0.45)* 3.35 2.67–4.21 2.61 2.31–2.95
CI, confidence interval. Sample sizes for chemical classes are approximate because sample sizes vary slightly by chemical.
aModels adjusted for age, race/ethnicity, education, smoking, parity, BMI, albumin, duration of fasting before specimen collection, and creatinine (only urinary chemical analytes 
adjusted for creatinine). bReference group is nonpregnant women. Chemical analyte concentrations are log-transformed. cLSGM (least-squares geometric mean) estimates are < LOD 
(see Table 3). *p < 0.10; **p < 0.01.NHANES and chemicals in pregnant women
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every U.S. location. Thus, the geographic vari-
ation in MTBE use may play a role in the 
wide exposure variability (Energy Information 
Administration 2008). PBDE-153 is another 
example of how geographic use variation can 
influence exposures levels. The 95th percentile 
of PBDE-153 levels is 15 times greater than 
the median, and previous research has found 
PBDE concentrations to be around two times 
higher in Californians than in others in the 
United States, likely because of California’s 
unique flammability standard (Zota et al. 
2008). Variation in exposure to chemical ana-
lytes used in consumer and personal care prod-
ucts (e.g., triclosan, where the 95th percentile 
is 35 times greater than the median) could 
be driven by unique product uses (Allmyr 
et al. 2009). Although biomonitoring stud-
ies can demonstrate variation in exposures 
within populations, they generally are limited 
in their ability to identify sources of exposures. 
Consequently, additional exposure assessment 
research is needed to identify the dominant 
sources of exposure among pregnant women 
and the general population.
Our analysis of the NHANES pregnancy 
data shows ubiquitous exposure to mul-
tiple chemicals during a sensitive period of 
fetal development. The NAS recommends 
accounting for both multiple exposures and 
exposures that occur during vulnerable devel-
opmental periods in improved approaches for 
assessing chemical risks across the population, 
which includes shifting to a risk assessment 
approach that presumes no threshold of effect 
among the population unless shown otherwise 
(National Research Council 2008b). Data, 
such as from NHANES, should be used to 
enhance our understanding of risks among 
the U.S. population and to inform further 
policy and research activities.
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